no icon
no icon
amc icon

Tata India Pharma And Healthcare Fund Regular Plan Idcw Reinvestment

Equity | Sector Specific - Pharma

(NAV as of 08/10/2024)
31.11 (1.69)

3Y Returns

20.39%

Min SIP

100

Min Lumpsum

5000

Expense Ratio

2.51%

Fund Size

519 Cr

Inception Date

28-Dec-15

Fund Manager

Meeta Shetty

Exit Load

0.25% on or before 30D.

Wealthzi View

Market Risk / Risk Taken Compared to Benchmark

Fund Size

SIP Returns

Risk Adjusted Returns

Extra Returns Over Benchmark

Returns Consistency

Performance Against Inflation

Overall Fund Zi Tag

Asset Allocation

Equity

98.59%

Debt & Others

1.41%

Market Cap Allocation

Large Cap

52.67%

Mid Cap

26.65%

Small Cap

19.83%

Other Cap

0.85%

Sector Allocation

Pharmaceuticals

75.61%

Health Care

14.92%

Cash/Deposits/Margins/Treps/Repo/Swaps

4.94%

Insurance

2.28%

Retailing

1.01%

Top Ten Holdings

Sun Pharmaceutical Industries Ltd

12.86%

Lupin Ltd

11.49%

Aurobindo Pharma Ltd

8.34%

Cipla Ltd

6.65%

Dr. Reddy'S Laboratories Ltd

5.27%

Investment Objective

Investment Objective Of The Scheme Is To Provide Long Term Capital Appreciation By Investing Predominantly In Equity/Equity Related Instruments Of The Companies In The Pharma&Healthcare Sectors In India. However, There Is No Assurance Or Guarantee That The Investment Objective Of The Scheme Will Be Achieved. The Scheme Does Not Assure Or Guarantee Any Returns.

Fund House Detail

AMC Name

Tata Asset Management Limited

Address

1903, B Wing, Parinee Crescenzo, G Block,Bandra Kurla Complex, Bandra East,Mumbai - 400 051

BUILD WEALTH WITH CONFIDENCE

no iconno iconno iconno icon
no icon

BSE Member code: 58371

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.
get on play storeget on app store

Wealthzi Investment Advisers (A division of Lime Internet Private Limited)

[CIN: U74999DL2017PTC310507] [PAN: AADCL2103M] [GSTIN: 07AADCL2103M1ZP]

[SEBI Registered Name: Lime Internet Private Limited] [SEBI RIA Registration No: INA000018133] [BASL Member ID: 2014] [Type of Registration: Non-Individual] [Validity of Registration: Perpetual] [Registered Address: Flat No. 603, 6th Floor, Kanchenjunga Building, 18 Barakhamba Road, New Delhi - 110001] [Principal Officer: Jyoti Prakash Nayak, Email: [email protected]] [Compliance Officer: Harshit Singh, Email: [email protected]] [Grievance Officer: Sanjeev Johari, Email: [email protected]]

[SEBI Regional Office Address: Securities and Exchange Board of India, NBCC Complex, Office Tower-1, 8th Floor, Plate B, East Kidwai Nagar, New Delhi - 110023, Ph: 011-69012998, Email: [email protected]]

Disclaimers:

Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Registration granted by SEBI, membership of BASL and certification from National Institute of Securities Markets (NISM) in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The information is only for consumption by the client and such material should not be redistributed.